|
|
 Ovarian Cancer |
 |
|
|
|
|
|
| (Page 1 of 8) « Back | 1 | 2 | 3 | 4 | 5 | Next » |
»
New mechanism explains Resistance of Ovarian Cancers To Platinum-based Chemotherapy
|
|
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature.
|
»
New mechanism explains resistance of some ovarian tumors to chemotherapy
|
|
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature.
|
»
Consuming a diet rich in flavonoids may be protective against Ovarian Cancer
|
|
New research out of the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including nonherbal tea and broccoli, was associated with a reduced risk of ovarian cancer. The researchers also found a decreased risk in women who consumed large amounts of the flavonoid luteolin, which is found in foods such as carrots, peppers, and cabbage.
|
»
Prognostic molecular markers for ovarian cancer
|
|
Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, according to new research.The kisspeptins, a family of peptide hormones, and the receptor GPR54 have previously been associated with anti-metastatic activity in certain human tumours. In this study, researchers have shown that kisspeptin and GPR54 are independent prognostic biomarkers specific for ovarian clear cell carcinoma - the first such markers to be identified.
|
»
Identifying indicators for ovarian cancer to improve early stage diagnosis
|
|
New research explains why some ovarian cancer patients are dying, while others survive, despite similar surgical and post-operative treatment. The findings show that the difference between life and death can many times be explained by the different biological properties of the tumors.
|
|
| (Page 1 of 8) « Back | 1 | 2 | 3 | 4 | 5 | Next » |
|
